nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—GALR3—Peptide GPCRs—GNRHR—adrenal gland cancer	0.141	0.141	CbGpPWpGaD
Ritodrine—GALR3—Peptide GPCRs—TSHR—adrenal gland cancer	0.0752	0.0752	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0444	0.0444	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0338	0.0338	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 signaling events—TSHR—adrenal gland cancer	0.0312	0.0312	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0272	0.0272	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0266	0.0266	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 trafficking events—TSHR—adrenal gland cancer	0.0246	0.0246	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0237	0.0237	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0203	0.0203	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0191	0.0191	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0183	0.0183	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—TSHR—adrenal gland cancer	0.0181	0.0181	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0174	0.0174	CbGpPWpGaD
Ritodrine—GALR3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0174	0.0174	CbGpPWpGaD
Ritodrine—PGD—Carbohydrate metabolism—PRKACA—adrenal gland cancer	0.0152	0.0152	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0139	0.0139	CbGpPWpGaD
Ritodrine—GALR3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0117	0.0117	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0115	0.0115	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0113	0.0113	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—GNAS—adrenal gland cancer	0.0105	0.0105	CbGpPWpGaD
Ritodrine—PGD—Disease—SH3KBP1—adrenal gland cancer	0.0104	0.0104	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0104	0.0104	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SDHB—adrenal gland cancer	0.0103	0.0103	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GNRHR—adrenal gland cancer	0.0103	0.0103	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0102	0.0102	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0101	0.0101	CbGpPWpGaD
Ritodrine—PGD—Disease—ZNRF3—adrenal gland cancer	0.00982	0.00982	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00954	0.00954	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0093	0.0093	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00927	0.00927	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00897	0.00897	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00771	0.00771	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—POMC—adrenal gland cancer	0.00708	0.00708	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00702	0.00702	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 signaling events—EGFR—adrenal gland cancer	0.0069	0.0069	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 trafficking events—CTNNB1—adrenal gland cancer	0.00688	0.00688	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00666	0.00666	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SDHD—adrenal gland cancer	0.00663	0.00663	CbGpPWpGaD
Ritodrine—PGD—Metabolism—RRM1—adrenal gland cancer	0.00663	0.00663	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00659	0.00659	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00622	0.00622	CbGpPWpGaD
Ritodrine—PGD—Disease—SPRY2—adrenal gland cancer	0.00615	0.00615	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00615	0.00615	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00606	0.00606	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00594	0.00594	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00569	0.00569	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00565	0.00565	CbGpPWpGaD
Ritodrine—PGD—Disease—MEN1—adrenal gland cancer	0.00564	0.00564	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00562	0.00562	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TSHR—adrenal gland cancer	0.00548	0.00548	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GNAS—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MEN1—adrenal gland cancer	0.00515	0.00515	CbGpPWpGaD
Ritodrine—PGD—Metabolism—MED12—adrenal gland cancer	0.00494	0.00494	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00462	0.00462	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00444	0.00444	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00435	0.00435	CbGpPWpGaD
Ritodrine—PGD—Disease—PRKACA—adrenal gland cancer	0.0043	0.0043	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00411	0.00411	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—POMC—adrenal gland cancer	0.004	0.004	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00395	0.00395	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00393	0.00393	CbGpPWpGaD
Ritodrine—PGD—Disease—CDC42—adrenal gland cancer	0.00365	0.00365	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—POMC—adrenal gland cancer	0.00363	0.00363	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PRKACA—adrenal gland cancer	0.0036	0.0036	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDC42—adrenal gland cancer	0.00334	0.00334	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF2—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GNAS—adrenal gland cancer	0.00319	0.00319	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF1R—adrenal gland cancer	0.00311	0.00311	CbGpPWpGaD
Ritodrine—PGD—Disease—TERT—adrenal gland cancer	0.00293	0.00293	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GNAS—adrenal gland cancer	0.00292	0.00292	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ABCB1—adrenal gland cancer	0.00287	0.00287	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TERT—adrenal gland cancer	0.00268	0.00268	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00261	0.00261	CbGpPWpGaD
Ritodrine—PGD—Disease—BAD—adrenal gland cancer	0.00255	0.00255	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00239	0.00239	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00237	0.00237	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00234	0.00234	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BAD—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Ritodrine—PGD—Disease—BRAF—adrenal gland cancer	0.00232	0.00232	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00217	0.00217	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—POMC—adrenal gland cancer	0.00215	0.00215	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BRAF—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—EGFR—adrenal gland cancer	0.00205	0.00205	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Ritodrine—PGD—Metabolism—POMC—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Ritodrine—PGD—Disease—PTGS2—adrenal gland cancer	0.00187	0.00187	CbGpPWpGaD
Ritodrine—PGD—Disease—CTNNB1—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	0.00161	0.00161	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTGS2—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00142	0.00142	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Ritodrine—PGD—Disease—EGFR—adrenal gland cancer	0.00133	0.00133	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EGFR—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TP53—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000911	0.000911	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000895	0.000895	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	0.000827	0.000827	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	0.000759	0.000759	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	0.000732	0.000732	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	0.000726	0.000726	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000708	0.000708	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	0.000609	0.000609	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	0.00053	0.00053	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	0.000489	0.000489	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	0.000482	0.000482	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000468	0.000468	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000349	0.000349	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	0.000276	0.000276	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	0.000232	0.000232	CbGpPWpGaD
